JP2005508172A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005508172A5 JP2005508172A5 JP2003541767A JP2003541767A JP2005508172A5 JP 2005508172 A5 JP2005508172 A5 JP 2005508172A5 JP 2003541767 A JP2003541767 A JP 2003541767A JP 2003541767 A JP2003541767 A JP 2003541767A JP 2005508172 A5 JP2005508172 A5 JP 2005508172A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- seq
- nucleic acid
- amino acid
- nucleotide sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 102000004196 processed proteins & peptides Human genes 0.000 claims 41
- 108090000765 processed proteins & peptides Proteins 0.000 claims 41
- 229920001184 polypeptide Polymers 0.000 claims 40
- 150000001875 compounds Chemical class 0.000 claims 33
- 102000039446 nucleic acids Human genes 0.000 claims 23
- 108020004707 nucleic acids Proteins 0.000 claims 23
- 150000007523 nucleic acids Chemical class 0.000 claims 23
- 239000002773 nucleotide Substances 0.000 claims 23
- 125000003729 nucleotide group Chemical group 0.000 claims 23
- 125000003275 alpha amino acid group Chemical group 0.000 claims 22
- 238000000034 method Methods 0.000 claims 12
- 208000014001 urinary system disease Diseases 0.000 claims 7
- 206010020718 hyperplasia Diseases 0.000 claims 6
- 206010046543 Urinary incontinence Diseases 0.000 claims 4
- 210000004027 cell Anatomy 0.000 claims 4
- 230000000694 effects Effects 0.000 claims 4
- 230000003321 amplification Effects 0.000 claims 3
- 238000003199 nucleic acid amplification method Methods 0.000 claims 3
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 claims 2
- 206010005052 Bladder irritation Diseases 0.000 claims 2
- 206010020853 Hypertonic bladder Diseases 0.000 claims 2
- 208000009722 Overactive Urinary Bladder Diseases 0.000 claims 2
- 206010060862 Prostate cancer Diseases 0.000 claims 2
- 208000004403 Prostatic Hyperplasia Diseases 0.000 claims 2
- 208000000236 Prostatic Neoplasms Diseases 0.000 claims 2
- 206010066218 Stress Urinary Incontinence Diseases 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 208000035475 disorder Diseases 0.000 claims 2
- 230000004064 dysfunction Effects 0.000 claims 2
- 208000017169 kidney disease Diseases 0.000 claims 2
- 210000000653 nervous system Anatomy 0.000 claims 2
- 208000020629 overactive bladder Diseases 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 201000007094 prostatitis Diseases 0.000 claims 2
- 210000003708 urethra Anatomy 0.000 claims 2
- 230000002485 urinary effect Effects 0.000 claims 2
- 230000000692 anti-sense effect Effects 0.000 claims 1
- 210000003443 bladder cell Anatomy 0.000 claims 1
- 210000005267 prostate cell Anatomy 0.000 claims 1
- 150000003384 small molecules Chemical class 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US34455201P | 2001-11-07 | 2001-11-07 | |
| PCT/US2002/035824 WO2003039475A2 (en) | 2001-11-07 | 2002-11-07 | Methods of identifying and using modulators of fractalkine receptor |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005508172A JP2005508172A (ja) | 2005-03-31 |
| JP2005508172A5 true JP2005508172A5 (enExample) | 2006-01-05 |
Family
ID=23351007
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003541767A Pending JP2005508172A (ja) | 2001-11-07 | 2002-11-07 | フラクタルカインレセプターのモジュレーターを同定する方法、およびフラクタルカインレセプターのモジュレーターを使用する方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20030104455A1 (enExample) |
| EP (1) | EP1441684A4 (enExample) |
| JP (1) | JP2005508172A (enExample) |
| AU (1) | AU2002360354A1 (enExample) |
| WO (1) | WO2003039475A2 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070298069A1 (en) * | 2006-06-26 | 2007-12-27 | Boston Scientific Scimed, Inc. | Medical devices for release of low solubility therapeutic agents |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUP9802678A3 (en) * | 1995-06-21 | 1999-12-28 | Shionogi & Co | Bicyclic amino derivatives and pgd2 antagonist containing the same |
| US6383746B1 (en) * | 1997-10-23 | 2002-05-07 | The United States Of America As Represented By The Department Of Health And Human Services | Functional promoter for CCR5 |
| US6103469A (en) * | 1997-11-07 | 2000-08-15 | Incyte Pharmaceuticals, Inc. | Human phospholipase A2 protein |
| US6140349A (en) * | 1998-02-02 | 2000-10-31 | Merck & Co., Inc. | Cyclic amine modulators of chemokine receptor activity |
| US6458549B2 (en) * | 1998-06-11 | 2002-10-01 | Winthrop-University Hospital | Methods of diagnosing renal salt wasting syndrome and Alzheimer's disease and methods of treating the same |
| US6008344A (en) * | 1999-02-23 | 1999-12-28 | Isis Pharmaceuticals Inc. | Antisense modulation of phospholipase A2 group IV expression |
| CA2362885A1 (en) * | 1999-03-11 | 2000-09-14 | Mount Sinai Hospital | Human kallikrein-like genes |
| AU2000273378A1 (en) * | 2000-02-18 | 2001-08-27 | Millennium Pharmaceuticals, Inc. | Therapeutic methods that target fractalkine or cx3cr1 |
| US20020115057A1 (en) * | 2000-09-18 | 2002-08-22 | Paul Young | Process for identifying anti-cancer therapeutic agents using cancer gene sets |
| US20030134324A1 (en) * | 2000-08-07 | 2003-07-17 | Munger William E. | Identifying drugs for and diagnosis of Benign Prostatic Hyperplasia using gene expression profiles |
| US20040048256A1 (en) * | 2001-09-07 | 2004-03-11 | Agee Michele L. | Novel proteins and nucleic acids encoding same |
-
2002
- 2002-11-07 US US10/290,058 patent/US20030104455A1/en not_active Abandoned
- 2002-11-07 WO PCT/US2002/035824 patent/WO2003039475A2/en not_active Ceased
- 2002-11-07 AU AU2002360354A patent/AU2002360354A1/en not_active Abandoned
- 2002-11-07 JP JP2003541767A patent/JP2005508172A/ja active Pending
- 2002-11-07 EP EP02795603A patent/EP1441684A4/en not_active Withdrawn